◉ Live · Brand communications for global pharma

Preparing the market.
Landing the launch.
Driving the change.

We are the strategic Brand Communications partner to global pharma — trusted by global brands since 2009, across every major therapeutic area from blockbuster brands to rare diseases, in 50+ countries.

We turn five billion real-time HCP signals into clinical-practice change — delivered at 30–40% below legacy agency benchmarks, because our AI-native infrastructure has been quietly doing the heavy lifting behind the scenes for eight years.

01 / Where we work

Across the lifecycle. One brand trajectory.

From Phase III preparation and launch through to lifecycle management of established and mature brands, we work alongside our clients across every stage of the brand journey — recalibrating depth of engagement to where each brand sits, and where it's headed.

Phase III

Preparing the market for launch.

Map the HCP information landscape. Track competitor positioning and activity. Surface white-space opportunity. Prime key segments so the launch lands into a market that's already listening.

Launch

Driving clinical-practice change.

Deliver brand uplift and lifecycle engagement as close to launch as possible — when switch propensity and share-of-voice are most malleable.

Established brand

Defending the position. Holding the share.

A light-touch engagement model for in-market brands — share-of-voice defense, competitor response, and lifecycle engagement calibrated to the steadier rhythm of an established brand. The same data layer and IQ Continuum, right-sized to the need.

Why this matters now
Field forces have contracted across every major market. HCPs are harder to reach in person, attention windows have narrowed, and launch budgets are scrutinised harder than ever. Commercial communications has gone from supporting the field to being the field. That's the job Fusion Brand Comms was built for.
02 / Approach

Four pillars. One engine.

Most agencies provide four services and call it integration. We run one engine that unifies insight, strategy, content and channel — so every recommendation can be traced from an HCP signal to a brand outcome.

01 / INSIGHT

Insight.

Powered by the IQ Continuum

Seven proprietary platform modules, surveying HCP information-seeking behaviour, competitor positioning and activity, stakeholder networks and congress dynamics — in real time, at global scale.

  • signalIQ — always-on HCP sentiment and share-of-voice
  • evidenceIQ — publication-landscape and gap intelligence
  • kolIQ — stakeholder influence and network mapping
  • congressIQ — congress impact and post-event activation
  • impactIQ — closed-loop ROE and attribution
02 / STRATEGY

Strategy.

POA-aligned · CSF-linked

Every recommendation we make is mapped to your Plan of Action and tied back to your brand Critical Success Factors. No vanity tactics. No strategy documents that forget why they exist by page four.

  • Launch sequence architecture, calibrated to competitive pace
  • HCP segmentation built on behaviour signals, not personas
  • White-space identification — where your brand can land uncontested
  • Channel portfolio logic backed by real-world reach data
03 / CONTENT

Content creation.

Peer-review-grade · Commercially sharp

Fully integrated content production — from brand campaigns and creative assets to HCP-facing scientific content. The rigour of our sister scientific arm, at the pace and fluency commercial teams need.

  • Launch campaigns and creative platforms
  • HCP and patient multichannel content at scale
  • Localisation across 30+ markets
  • Scientific and medical content fused with brand narrative
04 / CHANNEL + MEASUREMENT

Channel. Measurement. Optimisation.

Dynamic · Live, not post-mortem

Dynamically optimised channel spend, concentrated on the platforms and channels proven to drive HCP engagement and behavioural change — not reach, not impressions, not vanity. Every dollar, pound and euro works hard. Every asset carries its telemetry. Every tactic is re-optimised in-flight against POA KPIs and brand CSFs, not post-campaign.

  • Dynamic spend optimisation — budget follows performance, not legacy allocation
  • Platform selection driven by behavioural-change evidence, not reach claims
  • In-flight creative and channel reallocation — live, not post-mortem
  • Always-on CSF-linked dashboards — ROI transparency with the working shown
03 / See it in action

Live tools. Not slideware.

Working demos of the intelligence and planning platforms that power Fusion engagements — seeded with illustrative pharmaceutical datasets. The same modelling architecture runs against your real signals under MSA.

signalIQ · Planning platform

Understanding HCP interests through topic modelling.

Five billion signals on how HCPs seek information, engage with content, and move ideas through networks of influence — turned into a live map of what clinicians are actually thinking about, by therapy area, by market, by moment. The planning surface where every Fusion brand programme starts.

Biomarker-led selection Real-world evidence Combination therapy Switch propensity KOL network Safety MoA Dose escalation Biosimilar RWE Endpoint CLINICAL EVIDENCE TREATMENT DECISION INFLUENCE NETWORK

Sample view: topic clusters, illustrative oncology dataset. The live demo runs across additional behavioural signals.

Explore the topic modelling demo →
evidenceIQ · Channel & content engine

Persona-matched content & channel planning.

Four HCP persona archetypes, each mapped to content format, channel mix and engagement tactic. The planning surface where strategy becomes deployable — in your markets, against your CSFs.

Expert
Enhance
High product + TA knowledge
Peer networks · Long-form · Data-led
Senior
Differentiate
Competitive edge seekers
Positioning · Benefit · Head-to-head
Junior
Update
Building clinical base
Simplified · Digital-first · KOL-led
Mixed
Expand
Product-led, TA-curious
Educational · Peer insight · Broader TA

Sample view: oncology brand archetypes. Bespoke persona and channel modelling per client engagement.

04 / The IQ Continuum

Seven modules.
One evidence chain.

The decision-support system behind every Fusion engagement — brand, scientific, or cross-functional. Seven modules, shared with our scientific arm, each built to answer a specific commercial question and traceable back to the signal that prompted it.

The IQ Continuum Seven modules organised into a closed intelligence loop. signalIQ, evidenceIQ, kolIQ and congressIQ form the core loop, feeding impactIQ which reopens the cycle. activateIQ and procureIQ are cross-cutting predictive and governance layers. The IQ Continuum Seven modules. One evidence chain. Zero handoffs. The closed loop signalIQ Detect the shift evidenceIQ Diagnose the why kolIQ Identify the voices congressIQ Measure the moment impactIQ Attribute the change The loop reopens activateIQ Predictive layer — next-best-action modelling across every stage procureIQ Governance layer — spend, audit and AI-cost transparency end to end
05 / The data layer

Five billion real-world signals.
Across every brand moment.

5B+ data points
Real-world HCP information-seeking behaviour · Continuous, global, de-duplicated

Most agencies rely on intuition, legacy benchmarks, or small-sample research.

We hold over five billion real-world data points on how HCPs seek information globally — combined with continuous surveillance of competitor positioning and activity. The IQ Continuum is how we turn that scale into decisions your brand can act on tomorrow morning.

I.

White-space opportunity.

Where your brand can land uncontested — the intersection of unmet clinical need, competitor blind spots, and HCP information appetite that no one else is feeding.

II.

Competitor anticipation.

What your competitors will do, before they do it. Continuous monitoring of their scientific output, channel behaviour, KOL movements and narrative shifts — so you're reacting on Tuesday to what they'll announce on Friday.

III.

Launch-optimised sequencing.

What to say, to whom, through which channel, in what order. Our sequencing models are trained on real launch trajectories, not theoretical funnels.

LIVE DEMO The Planning Platform

Five billion signals. Mapped, modelled, made decisions.

Continuous intelligence across HCP information-seeking behaviour, literature and clinical evidence reviews, peer-to-peer discourse, and the networks of influence that move ideas through pharmaceutical communities. The substrate beneath every Fusion brand strategy.

06 / CSF alignment

Every plan. Every tactic.
Tied to your brand CSFs.

A brand plan that doesn't trace back to brand Critical Success Factors is a marketing exercise, not a commercial strategy. We design backwards from your CSFs — every recommendation, every asset, every pound of channel investment maps to a specific CSF and a specific POA milestone.

Start here

Brand CSFs

Your commercial success criteria — the outcomes brand leadership is measured on.

Step 02

POA milestones

Each CSF decomposed into Plan-of-Action checkpoints with measurable sub-outcomes.

Step 03

Tactics & assets

Every deliverable we produce carries a CSF tag — the reason it exists, the outcome it's measured against.

Step 04

Live reporting

Dashboards roll up tactic-level performance to CSF attainment. Live, not quarterly.

The test: when brand leadership asks "what moved the needle?" the answer isn't a vanity metric. It's the CSF — with the working shown, and the tactics that moved it named.

07 / Who we are

17 years in Pharma brand communications.
Built AI-native from the inside.

We are a Scientific and Brand communications entity that has spent those years delivering for global pharmaceutical clients — and the last eight of them quietly rebuilding the operating system of the category from AI-native foundations.

What most agencies are now attempting as an AI transition, we completed years ago. The result is the IQ Continuum: the only closed-loop intelligence system in pharmaceutical communications.

Since 2009
Reach 50+ markets
Pricing 30–40% below benchmark
Speed 2–3× faster delivery

Fusion wasn't built in a pitch deck. It was built across two eras of pharmaceutical communications — the one before AI changed the operating economics of the category, and the one we have been leading ever since.

Heritage era · 2009–2016
AI-native era · 2020–present
Heritage era
2009

Measuring impact

Global brand communications for pharmaceutical clients. The foundation on which everything that follows is built. Still the legal entity behind Fusion today.

Heritage era
2017

Communications + intelligence

Descriptive and predictive omnichannel analytics — the moment the business begins its shift from communications to intelligence. The first structural signal that the category was about to change, and we intended to change it.

Heritage era
2018

Global MSAs

Spanning multiple therapeutic areas globally, and Agency of Record status. These relationships prove, at category scale, that AI-native architecture and tier-1 pharma governance are not mutually exclusive.

AI-native era
2020

Humanised AI

Human-in-the-loop AI and ML for disease-area insights. The first proprietary AI module shipped under MSA — proof that this was never a wrapper around somebody else's model.

AI-native era
2020

Automated AI

ML-powered KOL mapping, identification and influence-network modelling. The first module to be adopted by another global agency as category infrastructure.

AI-native era
2023

fusion

Predictive modelling for HCP reach, engagement and launch optimisation. The moment the stack starts behaving as a system rather than a set of tools.

AI-native era
2024

Fusion consolidates the stack

Seven proprietary intelligence modules. One evidence chain. One closed loop.

AI-native era · Today
2026

The IQ Continuum ships

The category's first end-to-end closed-loop intelligence system for pharmaceutical communications.

8 / 8
Tap a year · or use ← →
Part of fusion
Commercial communications with a scientific backbone.

Fusion Brand Comms shares the IQ Continuum, data layer and governance with our scientific arm — fusionScientific. When your launch needs Medical Affairs rigour and commercial velocity in the same engagement, you get both from one partner. One evidence chain. One team.

Visit fusionScientific.io →
08 / Benchmark

Benchmark us against
your current agency.

If you're reviewing your brand communications partner ahead of a Phase III readout or launch window, the most useful thing we can do is put ourselves next to whoever you're working with now.

Send us your current scope. We'll come back with a like-for-like benchmark against our own methodology, five-billion-point data layer, and IQ Continuum capability — with the working shown.

◉ Procurement · Commercial brand agency transparency

Commercial procurement,
with the working shown.

Commercial brand spend is the single largest agency line on a pharma balance sheet — and still, mostly, the opaquest. Net-of-margin media, AI cost pass-through, creative IP, performance-linked commercials, and consolidation economics: Fusion was built from day one to answer every one of them without you having to ask.

Six commitments your commercial procurement team can bank, on the invoice, before the first deliverable ships.

What you get

Six commitments.
One invoice you can actually read.

01

Net media. Zero agency margin on platform spend.

Every pound of programmatic, social, search, DSP and professional-channel spend is passed through at net cost, itemised on the invoice. The 15–25% media margin most commercial agencies take quietly, we don't take at all. Our fees are on our services, not on your platform spend.

02

Fees that move when your CSFs move.

Because every tactic is CSF-tagged and measured live, we price against outcomes — not hours. Fixed-fee core scope, performance-linked bonus tied to CSF attainment. Your commercial team pays for what works, not for what was worked on.

03

All creative output belongs to you.

Every campaign, asset, creative platform and derivative work is assigned to the client on delivery. No licensing drip-back. No character rights retained. No "work-for-hire" ambiguity on page 34 of the SOW. If we made it on your programme, it's yours — to use, adapt, extend, or hand to another agency.

04

Every AI tool, itemised. Creative rates on AI-generated output, never.

Generative AI is now 30–50% of commercial creative production across the industry — with most agencies still charging full creative rates for the output. We disclose every AI tool used on your programme, pass its cost through at net, and price the human strategy and craft separately. Your procurement team sees what the machine cost and what the team cost. Line by line.

05

One partner for the stack your legacy setup uses five.

Most pharma brand teams currently run 5–8 specialist commercial vendors — creative, media, production, measurement, localisation, digital, influencer, scientific. Fusion consolidates that stack into one strategic partner with one contract, one invoice, one evidence chain. Typical consolidation recovers 20–35% of category spend in the first year, without losing specialism on any capability.

06

Tier-1 pharma governance since 2009.

Global MSA experience across 50+ markets. Standard terms aligned to the commercial procurement clauses that matter: IP assignment, data residency, sub-processor disclosure, AI model governance, audit rights, transparent compensation structures, and clean exit provisions. No hidden clauses. No white-label vendors buried three layers down.

The tool

procureIQ.
The category's first commercial-brand spend-transparency platform.

Our proprietary procurement intelligence module. procureIQ audits agency AI exposure, surfaces hidden media margin and cost pass-through, benchmarks category spend against a continuously updated efficiency index, and stress-tests performance-linked commercials. Built for commercial brand procurement, not retrofitted from a media audit template.

Typical commercial brand audits surface 40% savings; creative- and media-heavy categories, 45–55%. Available as a standalone engagement or embedded in an MSA.

Benchmark

Put us next to
your current commercial stack.

Share your current commercial brand scope — media, creative, production, measurement, localisation. We'll come back with a like-for-like benchmark against our methodology, our commercials, and our consolidation model. With the working shown. Under NDA on request.

◉ Contact · Let's talk

Contact us.

Whether you have a general enquiry or are interested in joining our team — we're always looking for people who share our ambition for pushing boundaries. If you're ready to challenge the way things are 'done' and can bring ideas to the table, please get in touch below.

Get in touch

Tell us what
you're working on.

Commercial brand teams, procurement leads, or anyone at a global pharma in a position to make a change. We reply to every enquiry within two working days.

General enquiries
Email address
Registered office
Fusion Agency Solutions Limited
Crown House, 27 Old Gloucester Street
London WC1N 3AX
United Kingdom
Company number
10572630 — registered in England and Wales
Thanks — your message is on its way.
We'll get back to you within two working days. For urgent enquiries, reach us directly at our inbox.